Completed

A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

I8F-MC-GPHU - ClinicalTrials.gov - NCT04407234

The purpose of this study is to learn more about how tirzepatide affects stomach emptying in overweight/ very overweight participants. Participants include those without diabetes and those with type 2 diabetes.
How long will I be in the trial?
Participation will last about 13 weeks, including screening.
Email
Completed

A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

I8F-MC-GPHU - ClinicalTrials.gov - NCT04407234

The purpose of this study is to learn more about how tirzepatide affects stomach emptying in overweight/ very overweight participants. Participants include those without diabetes and those with type 2 diabetes.
How long will I be in the trial?
Participation will last about 13 weeks, including screening.
Email

Key Requirements

Age :

18-65

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-65

Sex

All

Participants must

Participants must be overweight

Participants must agree to commit to and undergo study procedures as explained by clinic study staff

Participants must NOT

Participants must not have undergone weight loss surgery (e.g. stomach stapling, lapbanding)

Participants must not have used or intend to use weight loss drugs

Participants must not have made prior suicide attempts

Participants with type 2 diabetes must not have had more than 1 episode of severe low blood sugar that result in hospitalizations, emergency room visits or required someone else to administer treatment in the past 6 months

Trial Summary

Conditions the trial is for

Very Overweight, Adult Type 2 Diabetes, Overweight

What the trial is testing?

Tirzepatide

Could I receive a Placebo?

no

Enrollment Goal

36

Trial Dates

September 2020 - January 2021

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-65

Sex

All

Participants must

Participants must be overweight

Participants must agree to commit to and undergo study procedures as explained by clinic study staff

Participants must NOT

Participants must not have undergone weight loss surgery (e.g. stomach stapling, lapbanding)

Participants must not have used or intend to use weight loss drugs

Participants must not have made prior suicide attempts

Participants with type 2 diabetes must not have had more than 1 episode of severe low blood sugar that result in hospitalizations, emergency room visits or required someone else to administer treatment in the past 6 months

Trial Summary

Conditions the trial is for

Very Overweight, Adult Type 2 Diabetes, Overweight

What the trial is testing?

Tirzepatide

Could I receive a Placebo?

no

Enrollment Goal

36

Trial Dates

September 2020 - January 2021

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?